metformin has been researched along with 1-anilino-8-naphthalenesulfonate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, E; Blicklé, JF; Brogard, JM; Neyrolles, N | 1 |
| Bray, GA | 1 |
| Capuzzi , DM; Cohn, G; Valdes, G | 1 |
| Amamou, M; Ben, MH; Thabet, H; Zaghdoudi, I | 1 |
| Bouche, C; Goldfine, AB | 1 |
| Balci, MK; Coban, E; Sari, R; Yazicioglu, G | 1 |
| Bugianesi, E; Marchesini, G; Marzocchi, R; Villanova, N | 1 |
| Guo, X; He, J; Jiang, H; Pu, S; Xu, C; Xu, G; Zhang, T; Zu, L | 1 |
| Bryson, A; Groot, Gde H; Hallam, R; Hickling, RI; Kopelman, P; Palmer, R; Rissanen, A; Rossner, S; Toubro, S | 1 |
| Coker, RH; Kern, PA; Phanavanh, B; Ranganathan, G; Rasouli, N; Varma, V; Yao-Borengasser, A | 1 |
| Chen, MC; Chen, WL; Chiu, WZ; Hung, CC; Kang, CH; Lee, CC; Lee, HM; Lin, TH; Shieh, MS; Wei, HW | 1 |
| Dungan, CM; Frendo-Cumbo, S; Mennes, E; Williamson, DL; Wright, DC | 1 |
| Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Munda, P; Rechling, C; Trauner, M; Traussnigg, S | 1 |
| Cobelli, C; Irie, J; Itoh, H; Jinzaki, M; Kawai, T; Manesso, E; Meguro, S; Saisho, Y; Sugiura, H; Tanaka, K; Tanaka, M | 1 |
| Chen, J; Deng, H; He, B; Lyu, Q; Sun, Y; Wen, Y; Xiao, Q; Xu, L; Zhang, X; Zhao, Y | 1 |
6 review(s) available for metformin and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
[Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].
Topics: Administration, Oral; Chromans; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exercise; Fenfluramine; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lactones; Lipase; Metformin; Orlistat; Peroxisome Proliferators; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Drug treatment of obesity.
Topics: Androgen Antagonists; Androgens; Anti-Obesity Agents; Appetite Depressants; Caffeine; Central Nervous System Stimulants; Energy Metabolism; Enzyme Inhibitors; Ephedrine; Humans; Hypoglycemic Agents; Lactones; Lipase; Metformin; Obesity; Orlistat; Patient Selection | 1999 |
Pathophysiology and treatment of the dyslipidemia of insulin resistance.
Topics: Cardiovascular Diseases; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lactones; Life Style; Lipase; Metformin; Niacin; Orlistat; Risk Factors | 2001 |
Prevention of type 2 diabetes: are we ready?
Topics: Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lactones; Life Style; Lipase; Metformin; Orlistat; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
Topics: Antioxidants; Cholagogues and Choleretics; Cytoprotection; Enzyme Inhibitors; Fatty Liver; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lactones; Life Style; Lipase; Metformin; Orlistat; Phlebotomy; Thiazolidinediones; Ursodeoxycholic Acid | 2004 |
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Topics: Anticholesteremic Agents; Antioxidants; Bariatric Surgery; Carcinoma, Hepatocellular; Disease Progression; Genetic Variation; Humans; Hypoglycemic Agents; Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Membrane Proteins; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Prognosis; Receptors, Cytoplasmic and Nuclear; Vitamin E | 2015 |
3 trial(s) available for metformin and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women.
Topics: Adult; Dietary Fats; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Intestinal Absorption; Lactones; Lipase; Metformin; Middle Aged; Obesity; Orlistat; Prospective Studies; Statistics, Nonparametric | 2004 |
Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).
Topics: Adolescent; Adult; Aged; Benzoxazines; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Intention to Treat Analysis; Lactones; Lipase; Male; Metformin; Middle Aged; Obesity; Orlistat; Patient Selection; Treatment Outcome; Weight Loss | 2010 |
Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial.
Topics: Amylases; Blood Glucose; Body Fat Distribution; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Lipase; Liraglutide; Male; Metformin; Middle Aged; Obesity; Organ Size; Overweight; Radiography; Treatment Outcome | 2015 |
6 other study(ies) available for metformin and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Metformin associated acute pancreatitis.
Topics: Acute Disease; Adult; Amylases; Female; Humans; Hypoglycemic Agents; Lipase; Metformin; Pancreatitis; Suicide, Attempted | 2002 |
Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Carrier Proteins; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Fatty Acids, Nonesterified; Glycerol; Hypoglycemic Agents; Isoproterenol; Lipase; Lipolysis; Metformin; Mitogen-Activated Protein Kinases; Perilipin-1; Phosphoproteins; Rats; Rats, Sprague-Dawley | 2009 |
Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone.
Topics: 1-Acylglycerol-3-Phosphate O-Acyltransferase; Adipose Tissue; Bicycling; Body Mass Index; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipase; Male; Metformin; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Pioglitazone; Receptors, Adiponectin; Thiazolidinediones | 2011 |
Metformin regulates hepatic lipid metabolism through activating AMP-activated protein kinase and inducing ATGL in laying hens.
Topics: Abdominal Fat; AMP-Activated Protein Kinases; Animals; Body Weight; Chickens; Eating; Enzyme Activation; Enzyme Induction; Fatty Acids, Nonesterified; Female; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipid Metabolism; Liver; Metformin; Oviposition; Phosphorylation | 2011 |
Aging-associated reductions in lipolytic and mitochondrial proteins in mouse adipose tissue are not rescued by metformin treatment.
Topics: Adenosine Monophosphate; Adipose Tissue; Aging; AMP-Activated Protein Kinases; Animals; Blotting, Western; Down-Regulation; Fatty Acids, Nonesterified; Glucose; Glycerol; Homeostasis; Hypoglycemic Agents; Lipase; Male; Metformin; Mice; Mitochondrial Proteins; p38 Mitogen-Activated Protein Kinases; Phosphoenolpyruvate Carboxykinase (ATP); Protein Kinases; Proteins; Sterol Esterase | 2014 |
The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Fatty Acids, Nonesterified; Interleukin-6; Lipase; Metformin; Mice; Mice, Obese; Muscle, Skeletal; NF-kappa B; Obesity; RNA, Messenger; Sarcopenia; Sterol Esterase; Tumor Necrosis Factor-alpha | 2022 |